Skip to content

The Efficacy and Mechanisms of the "Jin's Three-Needle" Therapy for Severe Stroke Patients with Paralytic Ileus

The Efficacy and Mechanisms of the "Jin's Three-Needle" Therapy for Severe Stroke Patients with Gastrointestinal Paralysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000003
Enrollment
Unknown
Registered
2025-01-01
Start date
2025-01-06
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Stroke with Paralytic Ileus

Interventions

Acupuncture group :True acupuncture plus standard care
Sham acupuncture group:placebo acupuncture plus standard care

Sponsors

Zhongshan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the diagnostic criteria for severe stroke with a Glasgow Coma Scale (GCS) score =12. 2) Clinically confirmed diagnosis of paralytic ileus, with enteral nutrition administered for more than 48 hours. 3) Age between 18 and 65 years (18 = age < 65), with no restriction on gender. 4) Relatively stable vital signs for at least 24 hours, with an APACHE II score <31. The patient or their legal representative has been informed about the study and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to acupuncture (e.g., severe skin diseases, bleeding disorders, etc.). 2) Patients with severe cardiac, hepatic, or renal dysfunction; severe electrolyte imbalance (e.g., hypokalemia); or other serious systemic diseases. 3) Pregnant or breastfeeding women. 4) Patients with a history of severe primary gastrointestinal diseases (e.g., inflammatory bowel disease, irritable bowel syndrome, gastrointestinal bleeding, gastrointestinal perforation, functional constipation) or a history of gastrointestinal surgery (e.g., gastrointestinal stoma, extensive gastrointestinal resection). 5) Patients in a state of persistent agitation or status epilepticus, unable to cooperate with the study or potentially affecting study outcomes. 6) Patients who have received laxatives (e.g., lactulose) or prokinetic agents (e.g., neostigmine) prior to the trial. 7) Patients with a history of probiotic use within the past two weeks.

Design outcomes

Primary

MeasureTime frame
Weekly Spontaneous Bowel Movements (WSBM);

Secondary

MeasureTime frame
Use of Rescue Medications;Assessment of Bowel Movement Regularity;Abdominal Circumference;Bowel Sounds;Glasgow Coma Scale (GCS);National Institutes of Health Stroke Scale (NIHSS);Modified Rankin Scale (mRS);Length of Hospitalization;omics biomarkers;

Countries

China

Contacts

Public ContactLu Liming Jin Dan

Guangzhou University of Chinese Medicine

lulimingleon@gzucm.edu.cn13751779800

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026